Imaging Biometrics®, LLC (IB), a subsidiary of IQ-AI Limited (LON:IQAI) and the recognized leader in quantitative imaging analysis for brain tumor diagnosis and treatment, today announces it has taken its suite of products online via Arterys’s industry-leading medical AI platform. The products include IB Neuro, the premier magnetic resonance (MR) imaging dynamic susceptibility contrast (DSC) perfusion solution; IB DCE; IB’s Delta T1 mapping algorithm; and IB Diffusion.